首页> Cardio-oncology (London, England)> CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 - metastatic breast cancer.

CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 - metastatic breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Susan,Dent

第一单位： Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, NY, USA. susan_dent@urmc.rochester.edu.

作者： Susan,Dent ^[1] ; Avirup,Guha ^[2] ; Heather,Moore ^[3] ; Doris,Makari ^[4] ; Rachael,McCaleb ^[4] ; Irene,Arias ^[4] ; Stella,Stergiopoulos ^[4] ; Benjamin,Li ^[4] ; Michael,Fradley ^[5]

作者单位： Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, NY, USA. susan_dent@urmc.rochester.edu. ^[1] Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA. ^[2] Duke Cancer Institute, Department of Medicine, Duke University, Durham, NC, USA. ^[3] Pfizer Inc, New York, NY, USA. ^[4] Thalheimer Center for Cardio-Oncology, Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. ^[5]

关键词 Cardiovascular comorbidities Cyclin-dependent kinase 4/6 inhibitor HR?+?/HER2–Medical claims Metastatic breast cancer QTc prolongation Retrospective Torsades de Pointes

DOI 10.1186/s40959-025-00305-w

PMID 39871392

发布时间 2025-01-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cardio-oncology (London, England)

2025年11卷1期

7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cardio-oncology (London, England)

2025年11卷1期

7页

检索历史清除

CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 - metastatic breast cancer.

Cardio-oncology (London, England)

相似文献

同项目论文

Cardio-oncology (London, England)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 - metastatic breast cancer.

Cardio-oncology (London, England)

相似文献

同项目论文

Cardio-oncology (London, England)

相关期刊

检索历史清除